Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthea Wirges

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
JCI Insight|April 28, 2022
EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in miceArmin Rehm, Anthea Wirges, Dana Hoser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2022
EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effectsAnthea Wirges, Mario Bunse, Jara J Joedicke, et al.
Nature Communications|January 12, 2021
CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin's lymphoma and tumor-supportive follicular T helper cellsMario Bunse, Janina Pfeilschifter, Julia Bluhm, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
JCI Insight|April 28, 2022
EBAG9 controls CD8+ T cell memory formation responding to tumor challenge in miceArmin Rehm, Anthea Wirges, Dana Hoser, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2022
EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effectsAnthea Wirges, Mario Bunse, Jara J Joedicke, et al.
Nature Communications|January 12, 2021
CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin's lymphoma and tumor-supportive follicular T helper cellsMario Bunse, Janina Pfeilschifter, Julia Bluhm, et al.
Pageof 1